MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/90/0.1/20.09.24 Share Price

Warrant

DE000MG4D278

Real-time Bid/Ask 10:03:07 01/07/2024 BST
0.095 EUR / 0.124 EUR +22.22% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/90/0.1/20.09.24
Current month-85.48%
1 month-93.84%
Date Price Change
01/07/24 0.095 +5.56%
28/06/24 0.09 -14.29%
27/06/24 0.105 +14.13%
26/06/24 0.092 -8.00%
25/06/24 0.1 -29.08%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 09:45 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D27
ISINDE000MG4D278
Date issued 16/05/2024
Strike 90 $
Maturity 20/09/2024 (82 Days)
Parity 10 : 1
Emission price 1.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.55
Lowest since issue 0.088
Spread 0.029
Spread %23.39%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.09 USD
Average target price
83.43 USD
Spread / Average Target
+46.14%
Consensus